RespireRx Pharmaceuticals, Inc. engages in the discovery, development and commercialization of innovative pharmaceuticals for the treatment of neurological and psychiatric disorders. The company was founded by Carl W. Cotman, Wayne Pambianchi and Gary S. Lynch on February 10, 1987 and is headquartered in Glen Rock, NJ.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company